Cardiopulmonary exercise test safe in patients with PAH

June 2008
Cardiology Today;Jun2008, Vol. 11 Issue 6, p13
The article announces that cardiopulmonary exercise testing (CPET) would not harm stable patients with pulmonary arterial hypertension. It states that compared to a six minute walk test, CPET provides more accurate information about the patient's functional impairment. According to doctor Carmen Jiménez López-Guarcha of Hospital Universitario in Madrid, CPET can identify pathophysiologic mechanisms underlying exercise tolerance and could provide information that would help physicians determine if there is a need for a lung transplant.


Related Articles

  • Ausdauertraining bei Patienten mit pulmonaler arterieller Hypertonie -- Analyse der Effektivität und Sicherheit. Saxer, S.; Rhyner, M.; Treder, U.; Speich, R.; van Gestel, A. J. R. // Praxis (16618157);2/1/2012, Vol. 101 Issue 3, p163 

    Both in today's scientific research and in clinical practice, there exists a need to address the uncertainty concerning the effectiveness and safety of cardiopulmonary exercise training (CPET) in patients with pulmonary arterial hypertension (PAH). It is commonly believed that CPET may be...

  • Contrasting Cardiopulmonary Responses to Incremental Exercise in Patients with Schistosomiasis-Associated and Idiopathic Pulmonary Arterial Hypertension with Similar Resting Hemodynamic Impairment. Valois, Fabricio Martins; Nery, Luiz Eduardo; Ramos, Roberta Pulcheri; Ferreira, Eloara Vieira Machado; Silva, Celia Camelo; Neder, Jose Alberto; Ota-Arakaki, Jaquelina Sonoe // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    It has been reported that schistosomiasis-associated PAH (Sch-PAH) has a more benign clinical course compared with idiopathic PAH (IPAH). We therefore hypothesized that Sch-PAH subjects would present with less impaired cardiopulmonary and metabolic responses to exercise than IPAH patients, even...

  • Prognostic Relevance of Changes in Exercise Test Variables in Pulmonary Arterial Hypertension. Groepenhoff, Herman; Vonk-Noordegraaf, Anton; van de Veerdonk, Mariëlle C.; Boonstra, Anco; Westerhof, Nico; Bogaard, Harm J. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Introduction:Exercise variables determined in patients with pulmonary arterial hypertension (PAH) at the time of diagnosis, predict survival. It is unknown whether upon treatment, subsequent changes in these exercise variables reflect improvements in survival. The aim of this study was to...

  • Subject Index.  // Annals of Occupational Hygiene;2002, Vol. 46 Issue suppl_1, p459-u 

    A subject index of the "Annals of Occupational Hygiene" is presented.

  • Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension. Girerd, Barbara; Montani, David; Eyries, Mélanie; Yaici, Azzedine; Sztrymf, Benjamin; Coulet, Florence; Sitbon, Olivier; Simonneau, Gérald; Soubrier, Florent; Humbert, Marc // Respiratory Research;2010, Vol. 11, p73 

    Background: Previous studies indicate that patients with pulmonary arterial hypertension (PAH) carrying a mutation in the bone morphogenetic protein receptor type 2 (BMPR2) gene, develop the disease 10 years earlier than non-carriers, and have a more severe hemodynamic compromise at diagnosis. A...

  • A Treatment Algorithm for Pulmonary Arterial Hypertension. Galiè, Nazzareno // Advances in Pulmonary Hypertension;2014, Vol. 13 Issue 1, p31 

    The treatment algorithm for pulmonary arterial hypertension (PAH) represents graphically a sequence of operations that are needed for the management of patients. The treatment algorithm includes different types of recommendations with varying degrees of scientific evidence. The recommendations...

  • Endothelin : A tool for managing cardiopulmonary disease. Abdel-Razek, Tarek T.; Bennasir, Hassen; Sridhar, Shanmugam // Journal of Pharmacy Research;Feb2010, Vol. 3 Issue 2, p270 

    The inner cell lining layer of blood vessels termed endothelium plays an important role in the regulation of vascular function by producing a large number of biologically active substances that participate in the regulation of vascular tone, cell growth, inflammation, and thrombosis/...

  • Echocardiographic Predictors of Mortality in Patients with Pulmonary Hypertension and Cardiopulmonary Comorbidities. Steiner, Johannes; Wu, Wen-Chih; Jankowich, Matthew; Maron, Bradley A.; Sharma, Satish; Choudhary, Gaurav // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Objective: We aimed to identify the echocardiographic measures associated with survival in a patient population with a high prevalence of co-morbid cardiovascular and pulmonary disease that have significantly elevated estimated pulmonary artery systolic pressures (ePASP). Background: Pulmonary...

  • Comparison of 6-min walk test distance and cardiopulmonary exercise test performance in children with pulmonary hypertension. Lammers, Astrid E.; Diller, Gerhard-Paul; Odendaal, Dolf; Tailor, Sheila; Derrick, Graham; Haworth, Sheila G. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Feb2011, Vol. 96 Issue 2, p141 

    Objective To assess the relationship between 6-min walk test (6MWT) distance and variables of cardiopulmonary exercise testing (CPET) in children with pulmonary arterial hypertension (PAH). Design Retrospective study. Setting Tertiary hospital. Patients Children with PAH. Interventions CPETs and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics